Artes Medical’s dermal filler, ArteFill, is the first permanent wrinkle filler for the treatment of smile lines. The product was positioned as The First To Last® and launched using an innovative mix of online and classical marketing programs.
Cita led the ArteFill Launch Council that developed the commercialization strategy and implemented pre-commercialization plans including 100+ marketing initiatives from concept to completion.
A practice development program was developed for dermatology and plastic surgery offices to help differentiate ArteFill from temporary dermal fillers. In collaboration with sales, Cita led the execution of seasonal special offers and 350+ custom sales promotions to accelerate product acceptance.
A consumer pull-through campaign was launched using regional publications as well as MORE and O magazines in tandem with online media and promotional pricing specials.
ArteFill is now sold by Suneva Medical, a privately held medical technology company.